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ABSTRACT 
Dennefors, B., Studies on the endocrine function of the human ovary. Experi­
ments conducted on isolated ovarian compartments. Department of Obstetrics 
and Gynecology, University of Göteborg, 413 45 Göteborg, Sweden. 
Morphologically well characterized specimens from various compartments 
of the human ovary were isolated mechanically and incubated for short-time 
periods. The basal production of progesterone (P), androstenedione (A) and 
estradiol-17ß (E„), and the effects of human chorionic gonadotropin (hCG) 
on cyclic AMP (cAMP) and steroid formation, were investigated in vitro. In 
specimens from corpora lutea (CL) of different ages the influence of prosta­
glandins (PG:s) on these parameters also was studied. 
In the preovulatory follicle both the granulosa and the theca cells 
had the capacity to produce all three steroids measured in vitro. The domi­
nant steroid formed was P by granulosa cells and A by theca cells. was 
formed in considerable amounts by both cell types. These results demonstrate 
that steroidogenesis is not strictly compartmentalized in the human pre­
ovulatory follicle. Both cell types responded to hCG with increased cAMP 
and P formation. Thus, in the preovulatory follicle the granulosa cells 
develop a responsiveness to LH/hCG, which is of essential importance for 
normal follicular function and luteinization. 
In pieces of precisely dated human CL, hCG was found to stimulate cAMP 
and P formation at all ages of the CL. PGF? counteracted the stimulatory 
effect of hCG on both cAMP and P formation in CL of the mid-luteal phase, 
strongly indicating a luteolytic effect of in the human. 
Specimens from the stromal compartment of postmenopausal ovaries pro­
duced measurable amounts of all three steroids measured, with A being the 
major steroid formed. Hyperplastic stroma produced 2-fold higher amounts of 
A and E^ than atrophic stroma. Human CG had no effect on cAMP accumulation 
in atrophic stroma, while in hyperplastic stroma hCG elicited a marked in­
crease in cAMP formation, indicating a responsiveness to gonadotropin in 
this type of ovarian stroma. 
Hilus cells from postmenopausal ovaries:* showed a similar pattern of 
steroidogenesis in vitro to postmenopausal stroma, but the amounts of ste­
roids formed were clearly higher in hilus cells. The hilus cells responded 
to hCG with increased cAMP and steroid formation. It is suggested that the 
hilus cells form an additional functional compartment of the human ovary. 
Key words: ovary, human, theca cells, granulosa cells, corpus luteum, stroma, 
hilus cells, progesterone, androstenedione, estradiol, cyclic AMP, gonado­
tropin, prostaglandins. 
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INTRODUCTION 
As a part of the female reproductive system,the human ovary has a dual 
function: the production of germ cells and the secretion of sex steroid 
hormones. During the fertile period of life the endocrine activity of the 
ovary undergoes regular cyclic changes, which can be regarded as periodic 
preparations for fertilization and pregnancy, while around the menopause 
the endocrine function of the ovary changes dramatically. 
The endocrine activity of the ovary is located in different functional 
compartments with distinct morphological and functional characteristics. 
These compartments, however, are intimately linked to each other for modu­
lation of the total hormonal secretion from the ovary. 
Morphology 
The ovary of adult women consists of three reasonably well defined compart­
ments: the follicle, the corpus luteum (CL) and the stroma. Under the thin 
germinal epithelium covering the surface of the ovary and a more or less 
well defined layer of dense connective tissue (tunica albuginea), there is 
a thick layer of special connective tissue (cortex) in which are embedded 
the various sized follicles, the CL and the corpora albicantes. This inter­
stitial connective tissue of the cortex (cortical stroma) is composed of 
networks of reticular fibres and spindle shaped'cells, resembling smooth 
muscle cells (Bloom and Fawcett 1962). In addition, non-vascular autonomic 
nerves have been demonstrated in the stroma (Owman et al 1967). 
The mature follicle is a large vesicle containing the yellowish folli­
cular fluid surrounded by a capsule of two layers: the theca interna, highly 
vascularized with loosely arranged, large cells and the theca externa, with 
a dense structure of concentrically arranged, fusiform cells. The theca 
externa layer also contains smooth muscle cells in close contact with adre­
nergic and cholinergic nerve terminals (Owman et al 1975). There is no sharp 
limit between the theca externa and the surrounding cortical stroma, while 
the theca interna is separated by a basement membrane from the follicular 
epithelium lining the cavity (membrana granulosa). This follicular epithe­
lium consists of several layers of polyhedral cells (the granulosa cells) 
with no vascularization. The membrana granulosa is thickened on one side 
of the follicle (cumulus oophorus) where it surrounds the ovum. 
After rupture of the follicle and the discharge of the follicular fluid 
and the ovum with its cumulus oophorus, the follicle is transformed into a 
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CL. The granulosa and theca interna cells hypertrophy markedly, the nuclei 
enlarge and the cells gain lipoid material (luteinization). Accompanying CL 
development there is an intense vascular development throughout the granu­
losa layers which, like the theoa cells, become surrounded by a network of 
sinusoidal blood capillaries. The free space in the center of the CL is 
filled with the remains of the follicular fluid, transuded serum and erytro-
cytes (Bloom and Fawcett 1962). 
The ovarian cortex surrounds a medulla consisting of loose connective 
tissue (medullary stroma), large blood vessels and strands of smooth muscle 
fibres which extend into the ovary from its medial edge, the hilus. In the 
hilus of the ovary groups of large, epitheloid cells can be found in close 
connection with non-myelinated nerve fibres. These cells, which are morpho­
logically identical to testicular Leydig cells, are generally referred to 
as hilus or hilar cells (Sternberg 1949). 
In the years around the menopause, the remaining follicles and CL gra­
dually degenerate and disappear, while the stroma often shows nodular or 
diffuse proliferation (cortical stromal hyperplasia; see Fig 2, paper III). 
After menopause the hilus cells also may become more prominent (Boss et al 
1965). 
Endocrine function 
The main endocrine function of the human ovary is to produce and secrete 
steroid hormones: progestins, androgens and estrogens. This ovarian function 
has been studied indirectly by measuring sex steroid hormones in urine and 
peripheral blood during various stages of the menstrual cycle, after the 
menopause and after bilateral oophorectomy (for refs see Gurpide 1976). 
Since the adrenals also contribute substantially to the production of sex 
steroid hormones in the female, hormone determinations after supression of 
adrenal function or following adrenalectomy have given more selective in­
formation on the endocrine function of the ovary (for refs see Gurpide 1976). 
Human experiments, using infusion of exogenous gonadotropins followed by 
serial analyses of hormone levels in peripheral blood, have provided further 
knowledge of the endocrine capacity of the human ovary (e.g. Greenblatt et 
al 1976). In the last decades, analyses of hormones in the ovarian vein 
blood (e.g. Aedo et al 1980) have given more direct information on the hor­
monal secretion of the ovary. However, in vivo studies of this type only 
reflect the total sum of the hormones secreted by the different ovarian com­
partments. In order to study the function of the individual compartments, 
in vitro studies of well defined, isolated specimens from the ovary are 
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necessary. The vast majority of such studies have been performed in rats and 
other non-primate species, and have given new information and insight into 
the functional complexity of the different ovarian compartments. 
Our current knowledge of the endocrine function of the ovary may brief­
ly be summarized as follows. 
During the follicular phase,„the human ovary secretes estrogens (mainly 
estradiol-173 and estrone) in slowly increasing amounts followed by a dra­
matic acceleration the last four days of the follicular phase. Progesterone 
(P) is released in low amounts throughout this phase. The major ovarian 
source of these steroid hormones is the growing follicles, especially the 
large, preovulatory follicle. The site of steroidogenesis within the follic­
le is not fully clear to date. In several animal species (e.g. the rat) 
there is evidence that steroidogenesis is compartmentalized between the 
granulosa and theca cells, and that the theca cells produce and secrete 
mainly androgens which, in turn, are transported through the basement memb­
rane and aromatized to estrogens by the granulosa cells. This so called 
"two cell" hypothesis of follicular estrogen secretion originating from 
Falck's- work in the rat (Falck 1959) has been a matter of controversy, 
however, during the last decades and specific species differences seem to 
exist (for refs see Richards 198D). 
Starting on the day before ovulation, P secretion rapidly rises during 
the luteal phase, arid reaches its peak value around day 8 after ovulation. 
During the last 3-4 days of the luteal phase, P secretion quickly drops 
again, reflecting-the normal regression of the CL. Consequently, almost all 
P secreted by th e ovary during the luteal phase is derived from the CL. At 
the time of ovulation, the secretion of estrogens guickly declines to levels 
similar to those of the mid-follicular phase, whereafter a new, gradual in­
crease in estrogen secretion takes place. This second peak of estrogen out­
put reaches its maximum around the mid-luteal phase and then gradually 
declines. Estrogens secreted by th e human ovary during the luteal phase 
are produced predominantly by th e active CL, but to some extent also by the 
follicles. 
Also the secretion of androstenedione (A), the major androgen produced 
by the human ovary, fluctuates throughout the cycle with the highest amounts 
in the late follicular and early luteal phases. It appears that all three 
functional compartments of the ovary contribute to the total ovarian secre­
tion of A (Baird et al 1974 ). 
After menopause, the normal ovary secretes only minimal quantities of 
estrogens and P as judged by hormone levels in peripheral and ovarian venous 
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plasma (Judd et al 1974, Vermeulen 1976). However, the amounts of A and 
testosterone in the ovarian vein blood from postmenopausal women are almost 
within the same range as in premenopausal women (Greenblatt et al 1976). 
Ihese findings indicate that the postmenopausal ovary secretes mainly andro­
gens. Several in vitro studies have revealed that steroidogenesis in the 
postmenopausal ovary takes place in the stromal compartment (Rice and Savard 
1966, Mattingly and Huang 1969), and possibly also in the hilus cells 
(Scully and Cohen 1964). 
Gonadotropic regulation 
Ihe endocrine function of the ovary is regulated by gonadotropic hormones, 
which are essential for normal growth and development of the ovary. The 
gonadotropins in the cyclical woman are FSH, LH and prolactin and, during 
pregnancy, hCG and hPL also can be included. According to the classical 
view, FSH stimulates growth and ripening of the follicle and, in combination 
with LH, elicits full follicular maturation. The mid-cycle LH surge initia­
tes follicular rupture and CL formation. The function and survival of the 
CL thereafter is maintained by LH or hCG. 
In the last decade, results from numerous studies, both in vivo and 
in vitro, have modified this simple description of the gonadotropic actions, 
and the regulation of steroidogenesis in the ovary appears to be a complex 
system of steroid and protein hormone actions and interactions on the target 
cells. The present working hypothesis for the regulation of ovarian steroi­
dogenesis can briefly be summarized as follows. 
In the developing follicle FSH stimulates estradiol-17ß (E^) synthesis 
in the granulosa cells by activating the aromatase enzyme system (Moon et 
al 1978), and, as a consequence, increasing levels of not only FSH but also 
E2 are accumulating in the antral fluid. LH, on the other hand, stimulates 
the theca cells to an increased synthesis of androgens (Tsang et al 1979), 
which provide substrate for estrogen production. During the late follicular 
phase, when LH in serum rises to peak concentrations, this gonadotropin 
induces ovulation and stimulates luteinization of both theca and granulosa 
cells for the consequent formation of a CL. The role of prolactin in regu­
lating the steroidogenesis in the follicle is unclear, but it has been shown 
that high levels of prolactin in blood (hyperprolactinemia) and in folli­
cular fluid are associated with follicular atresia and depressed steroid 
secretion (McNatty et al 1974, McNatty 1979 ). 
As pointed out above, the CL_ needs support of LH for its survival 
(Vande Wiele 1970) and LH/hCG stimulates steroidogenesis in the CL. In 
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several non-primate species prolactin also is necessary for the maintenance 
and secretory activity of the CL (for refs see Rothchild 1981), while the 
role of prolactin for human luteal function remains somewhat controversial. 
If fertilization does not occur, the steroid secretion of the CL begins to 
decline by day 10-12 after ovulation, despite the fact that the CL is still 
exposed to certain amounts of circulating LH. The reasons for this so called 
functional luteolysis are still unclear. However, there is now strong evi­
dence in several animal species that local actions of prostaglandin 
(PGF~2a) in the ovary induce luteolysis (see below). 
Little is known about the role of gonadotropins for steroid production 
in the stromal compartment, but there are some indications that at least 
LH/hCG stimulates steroidogenesis in the ovarian stroma of both fertile 
(Rice and Savard 1966) and postmenopausal human ovaries (Poliak et al 1968). 
The mechanisms by which the gonadotropins act to regulate steroidoge­
nesis in their target cells in the ovary are still not known in detail. 
However, the initial step in the action of these protein hormones appears 
to involve binding of the hormone to a specific receptor on the cell memb­
rane. Binding to ovarian tissues is hormone-specific with the exception 
that LH and hCG probably compete for the same receptor. 
In the ovarian follicle of the rat, the theca cells have only LH/hCG 
receptors, while FSH receptors are located exclusively on the granulosa 
cells (Richards et al 1976). This latter cell type in the human has also 
LH/hCG receptors, the concentration of which increases during follicular 
development (Rajaniemi et al 1981). Furthermore, receptors for prolactin 
also have been detected on the granulosa cells of ovarian follicles in the 
pig (Rolland and Hammond 1975). The human CL has been found to contain 
receptors for LH/hCG (e.g. Lee et al 1973) as well as for prolactin (Mcteilly 
et al 1980). 
After binding of the gonadotropin to its receptor, the membrane bound 
enzyme adenylate cyclase (AC) is activated which in turn catalyzes conver­
sion of ATP to cyclic 3', 5'-adenosine monophosphate (cAMP). 
Role of the cAMP system 
Both FSH and LH/hCG have been shown to increase intracellular levels of cAMP 
in various ovarian cell types, and furthermore, an increase in cAMP forma­
tion after exposing ovarian specimens to gonadotropins is generally accepted 
as an indication of responsiveness to the gonadotropin. This increase in 
intracellular cAMP after stimulation with gonadotropins in vitro is a rapid 
process occurring within minutes (Nilsson et al 1974). 
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There is, to date, overwhelming evidence to support the "second messen­
ger" theory which implicates cAMP as an intracellular mediator for gonado­
tropic effects (Rail and Sutherland 1958). Within the cell, cAMP exerts its 
effect on steroidogenesis in a complex and incompletely understood way. 
However, it is known that cAMP binds to and activates a protein kinase 
which causes phosphorylation of protein substrates that regulate the func­
tional responses in the target cell (Davies et al 1978). 
Other regulatory factors 
All dynamic changes in the metabolism and steroid production of the various 
compartments of the ovary during the reproductive cycle are not exclusively 
regulated by gonadotropins or mediated by c AMP. Several local feed-back 
systems for steroidogenesis have been suggested. Such systems include local 
control by ovarian steroid hormones of certain steps in the steroidogenesis 
of the ovary plus a variety of intrafollicular peptide regulators such as 
inhibin (for refs see Channing 1979), FSH-binding inhibitor (Darga and 
Reichert 1978) and luteinizing inhibitor (Ledwitz-Rigby et al 1977). Further­
more, locally formed peptides with LHRH-like activity (gonadocrinins) have 
been suggested to influence ovarian function (Hsueh and Erickson 1979, Ying 
and Guillemin 1980), and the autonomic innervation of the ovary is probably 
also implicated in these regulatory systems (e.g. Owman et al 1967, Walles 
1977, Burden 1978). The significance of these suggested local regulatory 
mechanisms remains, however, a matter of debate and further studies have to 
be performed to clarify their physiological importance. 
The role of prostaglandins (PG:s) in regulating steroidogenesis in the 
ovary is another exiting field of exploration in the context of regulatory 
factors. PG:s of the E-type were originally proposed as obligatory media­
tors of LH induced stimulation of cAMP accumulation and steroidogenesis 
(Ku.ehl et :al 1970), but later studies have contradicted this hypothesis 
(for refs see Zor and Lamprecht 1977). Nowadays, the PG:s of the E-type are 
regarded more as modulators of gonadotropic effects. Another compound be­
longing to the group of classical PG:s, PGF2 , has been shown to induce 
luteolysis when administered to pseudopregnant rats, guinea pigs, hamsters, 
rabbits and rhesus monkeys (for refs see Horton and Poyser 1976). Attempts 
to demonstrate a luteolytic effect of PGF2 by systemic administration to 
humans have so far been fruitless, at least when given in tolerable doses 
(e.g. Jewelewicz et al 1972, LeHaire and Shapiro 1972). Therefore, at pre­
sent, it is not known if PGF? is luteolytic also in the human. 
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AIM OF THE PRESENT STUDY 
The research laboratory of this department (Dept. of Obstetrics and 
Gynecology) is working in close connection with the Endocrine division, 
Dept. of Physiology, University of Gothenburg. In this latter laboratory, 
extensive studies on the metabolism of the ovary and its gonadotropic cont­
rol have been performed during the last 20 years, mainly using the isolated 
rat ovary and its different compartments as experimental models. However, 
since there is a great variability in the ovarian endocrine function and 
its regulation between different species, results from experiments on rats 
and other laboratory animals cannot uncritically be extrapolated to the 
human situation. On the other hand, most of our current knowledge of human 
ovarian function originates from experiments on laboratory animals, from 
which the results have been confirmed or modified in subsequent human expe­
riments. In the last five years, our main purpose has been to transfer the 
detailed knowledge of experimental designs and results from studies on the 
rat ovary to experiments on the human ovary. The experimental techniques 
and analyses used in the present study are thus similar to those which have 
been applied in previous animal models. 
Host earlier studies on the in vitro metabolism of isolated compart­
ments from the human ovary have, with few exceptions, utilized cells or 
tissues from poorly characterized patients. However, exact estimations of 
the phase of the cycle are of crucial importance for interpretation of the 
results, since ovarian steroidogenesis is a dynamic system, undergoing con­
tinuous changes throughout the life span of the follicle or CL. Furthermore, 
when studying the endocrine activity of a specific compartment of the human 
ovary, it is necessary to characterize the isolated specimens morphologi­
cally to ensure that there is no contamination from other cell types and 
to identify possible signs of cellular abnormalities (degeneration, hyper­
plasia, neoplasia). Consequently, two basic aims of the present work were to 
isolate and morphologically characterize the various cellular compartments 
of the human ovary, and to analyse their in vitro steroid formation. The 
tissues were obtained from women who were carefully classified as regards 
the phase of the menstrual cycle or the postmenopausal period. 
Most earlier studies on the steroidogenic capacity of the human ovary 
have used long term tissue culture as experimental model. However, it is 
well known that the different cell types of the ovary may change morphologi­
cally and probably also functionally during culture. Furthermore, in long 
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term incubations, the availability of substrate and cofactors needed for 
steroidogenesis can never be exactly the same as in the in vivo situation. 
Therefore, in the present study we have used short term incubation periods 
(1-4 h), which are probably more "physiological" in this respect. 
The influences of gonadotropins on the human ovary vary markedly be­
tween different ovarian cell types and are dependent on the phase of the 
menstrual cycle. Therefore, another aim of the present study was to test the 
responsiveness of the various ovarian cell types to a gonadotropin (hCG), 
by measuring the acute effects on steroidogenesis and cAMP formation. In 
addition, comparisons were made between these effects in the different com­
partments of the human ovary. Human CG was chosen since it is a commercially 
available pure gonadotropin with biological effects very similar to LH. 
The mechanism underlying the normal regression of the CL of the cycle 
has been an attractive field of research during the last decade, probably 
because of its importance in relation to the control of fertility. In seve­
ral animal species PGF^ appears to be of physiological importance for in­
duction of luteolysis (for review see Horton and Poyser 1976). In the human, 
attempts to demonstrate a luteolytic effect of PGF, however, have yielded 
inconsistent results. Another aim of the present study was to determine 
whether PG:s (especially PGF^) are luteolytic also in the human. This 
possible luteolytic action was investigated by analyzing the influence of 
PG:s, in combination with hCG, on cAMP and P formation in isolated human CL 
of different ages. 
The hilus cells of the human ovary show histological and histochemical 
signs of secretory activity, and further, these cells are particularly pro­
minent during pregnancy and around the menopause, possibly indicating 
responsiveness to gonadotropins. Based on these findings it has been sugges­
ted that the ovarian hilus cells produce steroid hormones (Sternberg 1949). 
However, since no direct in vitro study of the proposed endocrine activity 
of these cells had been performed,the role of hilus cells in the steroid 
production of the human ovary was of specific interest to explore. The final 
aim of the present work was therefore to test microscopically defined speci­
mens from the hilus area of human postmenopausal ovaries for their steroido­
genic capacity and gonadotropic responsiveness in vitro. 
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In summary the purpose of the present study has been: 
1) to isolate and characterize cells from various compartments of the 
human ovary. 
2) to study specific aspects of steroidogenesis in granulosa and theca 
cells from preovulatory follicles, in CL of different ages, and in 
stromal and hilus cells from postmenopausal ovaries. 
3) to study gonadotropic influence on cAMP and steroid production in 
these various cell types derived from fertile and postmenopausal 
ovaries. 
4) to study the regulatory effects of PG:s on the function of the CL 
with special reference to luteolysis. 
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METHODOLOGICAL CONSIDERATIONS 
Patients 
Ovarian tissues were obtained from women undergoing laparotomy for various 
gynecological reasons. In paper I and II legal sterilization by tubal liga­
tion was the reason for surgery. All patients in these two studies had regu­
lar menstrual cycles and had no hormonal therapy for a minimum of 6 weeks 
prior to the operation. Estimation of the phase of the cycle was based on 
the following parameters: 1/ serum levels of P, E^ and LH taken 1-2 days 
before, during, and 2 and 5 days after the operation, 
2/ histological examination of an endometrial biopsy taken at operation, 
3/ day of last menstrual period (LMP). 
By combining these data, the day of the menstrual cycle at the time of 
surgery could be determined with a margin of - 24 h. Data from a typical 
patient are illustrated in Eig. 1. 
Statje of menstrual cycle 
CTKELPASBESTAMNING 
Date of operat 
Op.datum. 
Name 
. Samn^. JLEL. 
Born 
foi.dat. V¥ OS // 
vr/z. i /i s 
Estimated day of ovulatii 
„Beräknad 0Tulati0nsdag__ 
fu.C-*c (r*'Ui. 
endometrial biopsy 
PAD- put** t tage igte y 
?rovtagning(datum) 7/3 ?/3 "h /V/3 
S-progesteron nmol/lit 2-i ?.o /•i 0 
S-LH .ID/lit 10.H iC - -
Estradiol 17-ß nool/li- O.V 0.1 0./ _ 
nmol/l. ID/lit 
Estimated phase of cycle 
BERÄKHAD CYTffiLFAS  
7 dag 
Le$$ 4hâ* ^ le/»se. OVKU 
Eig. 1• Estimations of 
menstrual cycle phase. 
Summary of data from a 
typical patient inclu­
ding hormone blood 
levels, histology of 
endometrial biopsy and 
day of LMP. This patimt 
was operated on day 3 
and her hormone levels 
were indicative of ovu­
lation within 24 h of 
the operation. 
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All patients in paper III and IV were more than two years after the 
menopause; the lack of follicular function was confirmed by elevated serum 
levels of FSH (> 50 IU/1). These patients were operated on for various gyne­
cological disorders (fibroids, benign unilateral ovarian tumor, hydrosalpinx, 
atypical cells from- cervix or corpus uteri and, in one case, cancer of the 
uterine body). None of the patients had received radiotherapy or hormonal 
treatment within six months before surgery. Both ovaries were routinely 
removed and all macroscopically normal ovaries were used for the incubations. 
Isolation and incubation procedures 
Preovulatory follicles (paper I) : A small wedge resection of one ovary con­
taining the largest and most protruding follicle was performed during the 
operation, and the ovarian biopsy was immediately transported to the labo­
ratory in Krebs Ringer bicarbonate buffer (KRB) (see below) at room tempe­
rature. The follicle was then dissected free from surrounding tissues, the 
diameter was measured and the granulosa and theca cells were isolated as 
described in detail in paper I. No"attempt was made to separate the inner 
layers from the outer layers of granulosa cells, although there is evidence 
for a functional gradient within the membrana granulosa (Richards 1980). In 
all experiments the granulosa cells were counted in a haemocytometer and 
their viability was tested with 0.4% Trypan blue vital stain. In some experi­
ments histologic examination of the residual theca capsule was performed in 
order to check its purity (see below). The isolated cells were preincubated 
for 5 min and incubated for 30-240 min. 
Corpus luteum (paper II): The corpus luteum was excised in toto, placed in 
ice-chilled KRB and transported to the laboratory. The corpus luteum was 
then separated from adjacent tissues and dissected radially into small 
pieces, each with an approximate wet weight of 5-20 mg. These specimens 
were then preincubated for 60 min and incubated for 5-120 min. In certain 
experiments pieces of the corpus luteum were taken before incubation for 
histologic examinations (see below). 
Cortical stroma (paper III): Immediately after removal the postmenopausal 
ovaries were placed in ice-cold KRB and transported to the laboratory. The 
outer layer (2 mm) of the ovarian cortex was dissected free and the remai­
ning cortical tissue was cut into small pieces, each approx. 1-2 mm in size 
and a wet weight of 2-4 mg. Each piece of tissue was then cut into two 
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halves, one of which was fixed for histologic examination (see below). The 
other half was preincubated for 30 min and incubated for 240 min. 
Hilus cells (paper IV) : The postmenopausal ovaries were collected in the 
operating room and transported to the laboratory. Strips of hilus tissue 
(5x25 mm in size) adjacent to the ovarian margin were dissected free and 
divided into two halves, one of which was used for histologic characteriza­
tion (see below). The other half was cut. into numerous small'pieces. (approx. 
1x1 mm in size) which were preincubated for 30 min and then incubated for 
30 'or 240 min. 
Incubation medium: All incubations were performed in Krebs Ringer bicarbo­
nate buffer (see Umbreit et al 1964), pH 7.4, containing 1 m g/ml (5.5 mM) 
glucose and 0.1" (paper I) or 1% (paper II, III and IV) fatty acid free bovine 
serum albumin. A modification of the buffer was made by reducing the cal­
cium concentration from 2.5 mM to 1.25 mM in order to obtain a more physio­
logical concentration of free calcium ions. The buffer was oxygenated 
(95?i 0^ + 5% CO^) at the start of the preincubation period and -at the start 
of the incubation period to maintain optimal buffer capacity. When incuba­
tion time was 4 h, the incubation flasks were regassed after 2 h of incuba­
tion . 
General characteristics of isolated ovarian tissues 
Attempts were made to identify and morphologically characterize the diffe­
rent ovarian compartments which were isolated and incubated. The tissues 
were fixed in neutral 4% formaldehyde solution and light microscopical exa­
minations were performed. 
Preovulatory follicles: The follicular size and the status of the oocyte are 
described in paper I. The number of granulosa cells varied with the dia­
meter of the follicles: minimum diameter 12 mm - 7 million cells, .maximum 
diameter 30 mm - 40 million cells. The viability of the granulosa cells, as 
estimated with Trypan blue stain, was found to be 60 - 70?é. Each aliquot of 
incubated cells contained approx. 0.5 million viable granulosa cells. 
The residual theca capsule wasj.carefully checked for contamination of granu­
losa cells. These theca capsules were found generally, to be free from con­
taminating granulosa cells with the exception of occasional small patches 
made up of 1-2 layers of granulosa cells. 
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Corpus luteum: The corpus luteum could easily be identified macroscopically. 
In certain experiments portions of the corpus luteum were examined histo­
logically and were found to be normal. Attempts to classify the age of the 
corpus luteum based on histologic appearance of the luteinized cells were 
discarded, since this method proved to give less exact estimation of the 
age of the corpus luteum compared to the other utilized methods. 
Cortical stroma: Since the ovarian stroma is, macroscopically, a less dis­
tinguishable compartment than the follicle or the corpus luteum, the oppo­
site half of each incubated piece of stroma tissue was examined histologi­
cally to ensure that no other active ovarian structures were included. 
According to the structure of the stroma the cases could be divided into 
two groups: "normal", atrophic stroma and stromal hyperplasia. For 'further 
details see paper III. 
Hilus cells: The hilus cells are difficult to identify in small specimens 
from the hilus region, since these cells are located in irregularly scattered 
nests throughout the hilus. For such reasons the intact half of the whole 
strip from the hilus was examined histologically. Only cases where this half 
of tissue showed clusters of typical hilus cells and no fragments of corti­
cal or medullary stroma were included in the study. Furthermore, since the 
other structures of the hilus (i.e. muscle cells, vessels, nerves, connec­
tive tissue) are not known to produce any of the steroids measured, and 
since all specimens selected were found to release measureable amounts of 
steroids into the incubation medium, this technique to identify hilus cells 
seems feasable. 
Hormone preparations 
A general problem in experiments dealing with hypophyseal gonadotropic 
hormones is the difficulty in obtaining pure preparations. One aim of the 
present study was to test the effects of one gonadotropin on the various 
compartments of the ovary. Human CG was chosen since it was possible to 
obtain it in a very pure form. Human CG competes for the same receptors as 
LH and has many similar effects. It must be kept in mind, however, that 
there are also differences in the biological, especially long-term, effects 
of hCG and LH both in experimental investigations and in clinical practice 
(e.g. Ahrén et al 1980). Highly purified human CG was a gift from Leo Ltd., 
Helsingborg, Sweden (activity 6000 IU/mg in paper III, 10000 IU/mg in paper I, 
II and IV). Prostaglandin E2 and V (paper II) dry- substance (a gift from 
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Upjohn Co., Kalamazoo, USA) were dissolved in 95% ethanol (stock solution 
1 mg/ml). Immediately prior to use, these PG solutions were diluted with 
buffer to give a final concentration of 1 ug/ml (ethanol conc. 0.150- In 
certain experiments on human CL only the ethanol vehicle was added to the 
incubation medium in the final concentration of 0.1?o. It was found that this 
amount of ethanol did not interfere with the steroid or cAMP formation i_n 
vitro. 
Determination of cAMP 
Following incubation the ovarian specimens were homogenized in 1.2 ml 5% 
trichloroacetic acid (ICA). Samples of the homogenates were taken for deter­
mination of protein content according to Lowry et al (1951). After centri-
fugation 50 yl of HCl was added to the supernatant and the TCA was removed 
by wa shing the samples with dietyl ether 6 times. The agueous phase was 
evaporated to dryness under a stream of air, and the residue was dissolved 
in 0.05 M sodium acetate buffer and used directly for the cAMP assay. Cyclic 
AMP was determined according to the protein binding assay of Gilman (1970) 
with the following modifications: albumin 1°o was used instead of protein 
kinase inhibitor, and dextran coated charcoal instead of rnillipore filter 
for the separation of bound and free cAMP. Standards ranging from 0.5 -
100 pmol were assayed together with the unknown samples in duplicates. The 
unknown samples were calculated from the standard curve which was expressed 
using the logit-log transformation. 
Steroid formation in vitro 
The steroids progesterone (P), androstenedione (A) and 17ß-estradiol (E^) 
were measured since these three steroids represent the three major groups 
of sex-steroid hormones produced by th e human ovary. The release of these 
steroids into the incubation medium during various incubation periods and 
the content in follicular fluid were measured by radioimmunological tech-
nigue (RIA). 
In certain experiments (on theca and luteal cells) the release of 
estrone into the incubation medium also was measured by RIA. A good correla­
tion between the amounts-of estrone and was then found both for controls 
and hCG-treated specimens (r = 0.93). However, estrone levels in the incuba­
tion media were generally 5-10 fold lower than those of 
In one series of experiments the tissue levels of the steroids in 
granulosa and theca cells from preovulatory follicles were measured and 
compared to the levels in the incubation medium after the incubation period 
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(Table I). This comparison showed that the steroid levels in the incubation 
medium were 2-50 fold higher than in the tissue (highest difference for 
granulosa P and lowest for granulosa E?). 
Table I. Comparisons between steroid amounts in the incubation medium and 
in the tissue of granulosa and theca cells. 
Treatment Steroid concentration 
(ng/mg protein) 
tissue medium 
GRANULOSA progesterone C 7.2-3.9 221.4 - 19.5 
CELLS f& 
hCG 
(100 IU/ml) 7.3 Î 0.9 If!09.3 Î 37.4 
androstene-
dione C 0.9 î 0.2 5.3 - O.B 
hCG 
(100 IU/ml) 2.5 î 0.4 6.6 î 0.5 
estradiol C 25.3 i 7.1 53.8 î 10.8 
hCG 
(100 IU/ml) 34.5 i 1.4 106.4 - 14.8 
THECA androstene-
dione C . 7.0 i 1 .7 87.7 18.6 
CELLS 
hCG 
(100 IU/ml) 5.6 ^ 2.0 171.2 - 23.3 
The granulosa cells were derived from a healthy preovulatory follicle 
(incubation time 4 h) and the theca cells from an atretic follicle (incu­
bation time 2 h). Values are given as mean - SEM. The amounts of steroids 
are 2-50 fold higher in medium than in tissue. 
To test whether the release of steroids into the incubation medium 
reflects de novo synthesis or release of preformed steroids, aminoglute-
thimide, a potent inhibitor of steroidogenesis, was added to the incubation 
medium of granulosa and theca cells. Aminoglutethind.de (Ag Elipten, kindly 
donated by Ciba-Geigy Pharmaceutical Co, Sweden) was used in a concentra­
tion of 1 mijjjimoles/l. The results are shown in Table II. The average in­
hibition of steroid release was found to be 50% for granulosa cells and 
40?o for theca cells. 
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Table II. Effects of aminoglutethimide (Ag) 1 mM on the release of steroids into the incubation medium during a 2 h 
incubation period of granulosa and theca cells. 
Steroid release (ng/mg protein) 
C Ag hCG(100 IU/ml) hCG (100 IU/ml)+ Ag average inhib. 
GRANULOSA progesterone 4.8-0.5 0.8-0.1 - - 17?i 
CELLS 
androstenedione 1.7-0.2 1.2-0.3 - - 75?0 
estradiol 0 . 2 -  0.0 0.1 i 0.1 - - 50S 
TIRA progesterone 07 J i 37.2 74.5 t 9.3 540.2 î 265.5 78.« - 9-5 2» 
CELLS 
androstenedione 87-7 - 16.8 49.1 - 35.8 - - 37?q 
estradiol 11.2Î 2» 8.7 i 2.0 50.1 t 10.2 16.3 ±8.3 41Ä 
Values are given as mean - SEM. The cells were derived from a large human, atretic follicle (not included in the 
study) of a patient who had been primed with Clomiphene and hCG for oocyte collection. 
In certain experiments the incubation media were frozen immediately 
after the preincubation period and were later analysed for steroids. It was 
then found that the steroid concentrations in these preincubation media were 
approx. 50% of the concentrations measured after the 2 h incubation period. 
Considering the scope of the methods applied in this study, it is con­
cluded that steroid release from tissues into their incubation media during 
2-4 h incubations can be closely correlated with de novo steroid synthesis 
in the incubated specimens. 
Radioimmunoassays of steroid hormones 
The three steroids; were determined by RIA using antisera which were raised 
and characterized in the Department of Hormone Research, The Weizmann Insti­
tute of Science, Israel. The antisera were prepared by immunizing rabbits 
with BSA-conjugates of progesterone-11a-hemisuccinate, 17g-estradiol-6-
carboxymethyloxime and androstenedione-7-carboxy-ethylthioether. It has 
previously been demonstrated that these antisera are of high specificity 
and that the cross-reactivity between important steroid hormones is low 
(Lindner and Bauminger 1974). 
Progesterone : For estimation of progesterone, 25 or 50 til aliquots of incubation 
medium were transferred to extraction tubes and were brought to a volume of 
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500 yl with a solution containing 50 mM Tris-HCL hydroxymethylaminomethane, 
100 mM NaCl and 15 mM NaN^ ("Tris I"), all adjusted to pH 10 with one drop 
of1M NaOH.and extracted with 10 ml of petroleum ether. The extraction tubes 
were shaken vigorously for 1 min. The recovery of radioactivity when pure 
H -progesterone was added to samples before extraction and portions of the 
extract directly counted was approx. 91%. 500 ul of the ether extracts were 
transferred to glass tubes and evaporated to dryness under a stream of 
nitrogen. The dried extract was re-suspended in 400 pi Tris HCl buffer (pH 8) 
containing 0.3% normal rabbit serum ("Tris II"). The tubes were incubated 
for 10 min at 60°C and placed on ice. To each sample was then added 200 pi 
of an antibody-^H -progesterone mixture prepared immediately before the 
addition. The amount of H^ -progesterone (1, 2, 6, 7-^H -progesterone pur­
chased from the Radiochemical Centre, Amersham, England) was adjusted to 
give a final concentration of 4000 cpm/600 pi. The radioactive progesterone 
was regularly re-chromatographed on Sephadex LH-20 column (see below). A 
stock solution was made in toluene:methanol 85:15 to a concentration of 
approx. 10^ cpm/ml and stored at 4°C. When making solutions for an assay, 
50 vil of this stock solution was evaporated under nitrogen and the dried 
residue dissolved in an appropriate volume of Tris II. 
After adding the antibody-^H -progesterone mixture the samples were 
incubated over night at 4°C. The separation of bound and unbound steroid 
was achieved by adding 100 pi ice-chilled dextran coated charcoal, mixed, 
incubated for 20 min at 4°C, and centrifuged at 4000 x g in a swing-out-
centrifuge for 30 min at 4°C. After centrifugation the supernatant was 
rapidly transferred to a scintillation vial and mixed with 3 ml RIA-luma 
(Lumac B.V.). All samples were counted in a Packard Tric-Carb liguid scin­
tillation spectrometer (model 2450). 
Standards were prepared by dissolving unlabelled progesterone (from a 
stock ethanol solution) in Tris II. The final amount of unlabelled proges­
terone in the reaction mixture was 0, 6.25 (only in paper I and II), 12.5, 
25, 50, 100, 200, 400 and 800 pq in 600 pi. Also blank tubes and tracer 
tubes were included in the assay to give unspecific binding and total radio­
activity respectively. The ratio between total amount of -progesterone 
bound (corrected for unspecific binding) and total amount added, was 51.3 
- 3.8?; (mean - SEN of 9 separate analyses). The standards and unknown samp­
les were run in duplicates. The unknowns were calculated from the standard 
curve which was expressed using logit-log transformation. 
For measurement of the tissue levels of progesterone in granulosa and 
theca cells, the incubated specimens were homogenized in 1.0 ml ethanol (99%) 
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and centrifuged at 1000 x g for 20 min at 4°C. Aliquots of the supernatant 
were extracted with petroleum ether and the extracts were assayed as descri­
bed above for the medium. 
The specificity of the RIA under the described conditions was analysed 
by comparing values from crude extracts of incubation medium to values 
obtained from extracts purified by Sephadex LH-20-chromatography according 
to Carr et al (1971). The solvent system Heptane 85: Benzene 10: Methanol 
5, was used in 8 x 100 mm glass columns containing 0.8 g Sephadex. To 
correct for procedure losses, pure -progesterone was added before chroma­
tography and a portion of the appropriate fraction was taken directly for 
liquid scintillation counting. The recovery of radioactive progesterone 
averaged 89%. As shown in Table III there was good agreement between RIA-
values obtained from the crude petroleum ether extract and from the puri­
fied fraction (r = 0.94). 
Table III. Comparisons of steroid determinations obtained by RIA applied to 
extracts of incubation media with or without chromatographic purification. 
Steroid without chromatography with chromatography 
(ng/mg protein) (ng/rng protein) 
Progesterone 1G8.7 126.4 
152.5 160.2 
200.9 181.3 
181.6 190.1 
r = 0.94 
Andrastenedione 3.97 4.96 
70.73 '53.38 
51.86 61.01 
85.13 111,55 
30.09 37.76 
50.13 45.01 
32.60 36.67 
r = 0.91 
Estradiol -176 2.77; 1.82 
4.45 5.05 
12.05 7.08 
9.76 6.53 
9.42 -" !5.55 
11.04 12.07 
13.60 10.13 
48.37 45.70 
r = 0.99 
The individual values are derived from several different experiments. 
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The sensitivity of the assay was determined by assaying aliquots of 
medium which had been incubated without tissue. The medium blank value was 
3 A - 0.9 pg (mean - SEM of 5 separate analyses). The lowest detectable 
amounts of progesterone in 600 pi was therefore considered equal to the 
lowest amount of unlabelled progesterone in the standard curve, i.e. 6.25 
pg/600 pi (12.5 pg/600 yl in paper III and IV). 
The reliability of the method was controlled by including samples from 
a pool of progesterone (dissolved in ethanol and diluted with Tris I and 
kept at -20°C). The between-assay coefficient of variation (CV) when ana­
lysing aliquots of this pool containing 800 pg progesterone was 16.3°o and 
the average within-assay CV was 8.5% (6 analyses). 
In several analyses, different amounts of unlabelled progesterone were 
dissolved in the albumin-containing incubation medium and processed as 
described above. The recovery varied between 96 and 100?o. One such analysis 
is shown in Table IV. Based on these findings, recovery experiments were 
not run routinely for all assays. 
By taking different volumes of incubation medium for RIA it was also 
shown that parallelism existed. 
Table IV. Relationship between the amount of steroid added to the incubation 
medium and that measured by RIA. 
ng steroid added ng steroid measured 
progesterone androstenedione estradiol —173 
0.16 0.20 0.18 
-
0.32 
-
0.28 0.31 
0.63 0.49 
-
0.61 
1 .25 1.77 1 .90 1 .29 
2.50 2.45 3.50 2.60 
5 5.15 5.74 4.89 
10 9.76 9.21 8.09 
20 18.72 21.06 _ 
Different amounts of unlabelled steroids were dissolved in the albumin-
containing medium and incubated for 2 h at 37°C. Aliquots of the medium 
were extracted for RIA. 
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Estradiol and androstenedione: The assay procedure for determination of E^ 
and A was similar to that described for P with the following exceptions: the 
extraction of steroids from the incubation medium or homogenate of folli­
cular cells was performed with 5 ml diethylether. After separation the 
aqueous layer was frozen in an ethanol dry-ice mixture and the ether phase 
was decanted into conical tubes and evaporated under nitrogen. The dried 
steroids were re-dissolved in 1 ml acetone and 200 yl of this acetone-
extract was transferred to glass tubes and evaporated.under nitrogen. There­
after the steroid was dissolved in 400 yl Tris II and the rest of the assay 
was proceeded as described for P. 
Stock solutions of labelled steroids (2, 4, 6, 7 -'h -E and 1, 2 -'h -A 
from New England Nuclear, Boston, USA) in toluene:methanol (85:15) were 
kept refrigerated at 4°0. 'hi -Z was added to a concentration of 10,000 cpm 
(approx. 80 pg) / 600 yl and 'h -A to 4000 cpm (60 pg) / 600 yl. The ratio 
between total amount of bound radioactivity and total amount added was 
39.6 - 2.5°é (mean - SEM, 12 separate analyses) for A and 47.0 - 2.1% (mean 
- SEM, 13 separate analyses) for E . The purity of labelled hormones was 
confirmed by Sephadex LH-20 column chromatography. 
The specificity of the two RIA:s was confirmed by comparing values 
obtained by analysing crude ether extracts and purified fractions of the 
steroids. Both steroids were purified by Sephadex LH-20 column chromato­
graphy as described for P using the solvent system Heptan 85: Benzene 10: 
Methanol 5 (A) and Benzene 90: Methanol 10 (E^). As shown in Table III, simi­
lar values were found whether crude or purified extracts were analysed for 
both steroids. 
The sensitivity of the RIA:s was 11.2 - 3.0 pg/600 yl (mean - SEM, 3 
separate analyses) for and 10.6 - 2.1 pg/600 yl (mean - SEM, 5 separate 
analyses) for A. 
The reliability of both assays was analysed as described for P. The 
between-assay CV was 16.1 ?o (E^) and B.9S (A). The within-assay CV averaged 
8.7?o for E ^ and 7.9?o for A (6 analyses). 
When different amounts of unlabelled steroids were added to the incu­
bation medium, extracted and assayed, good agreement was found for both 
steroids between the amount added and that measured,as shown in Table IV. 
It was further shown, for both steroids, that parallelism existed when 
different volumes of incubation medium were taken for RIA. 
The recovery of radioactivity when -labelled steroids were added 
to samples and extracted with ether averaged 98% for both steroids. 
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Since the extraction of all three steroids measured was efficient and 
since the medium blank values (see above) were below or near the sensitivity 
limit of the standard curve (6.25 - 12.5 pg/600 pi), no correction was made 
for recovery or medium blanks. 
Statistics 
-f. 
Values are generally expressed as mean - SEM. Comparisons between two groups 
were made using Student's t-test and between several groups by analysis of 
variance followed by Student-Newman-Keul's multiple range test (Wolf 1968). 
A p-valu e less than 0.05 was considered significant. 
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RESULTS AND COMMENTS 
The main resuits of papers I — IV are summarized and commented on in this 
section. More detailed considerations concerning the interpretation of the 
results will be given in "General discussion". 
Steroidoqenesis and hCG-responsiveness of isolated cells from preovulatory 
follicles (paper I). 
It was demonstrated in paper I that both theca and granulosa cells from 
healthy, preovulatory follicles had the capacity to synthesize all three 
steroids as measured in vitro. The predominant steroid formed was P for 
granulosa cells and A for theca cells, while E? was formed in similar amounts 
by both cell types. From animal studies it has been claimed that steroido­
genesis in the follicle is compartmentalized between the granulosa and the 
theca cells and that an interaction between these two cell types is requi­
red for the production of estrogens in the follicle (for refs see Armstrong 
and Dorrington 1977). Whether this theory is valid also in the human has 
been a matter of debate since different in vitro studies have yielded contra­
dictory results. One reason for this may be that most earlier studies on the 
steroidogenic activity of human follicular cells were made without any know­
ledge as to the stage of follicular maturation or degree of atresia. There­
fore, all follicles of the present study were carefully examined to assess 
that they were healthy and fully developed. 
The findings of the present study demonstrate that, in the human pre­
ovulatory follicle, steroidogenesis is not rigidly compartmentalized between 
granulosa and theca cells. 
In the present study it was further demonstrated that hCG stimulated 
cAMP formation in both granulosa and theca cells derived from preovulatory 
follicles. In addition, hCG stimulated the formation of P and A in the theca 
cells, but had no significant effect on these steroids in granulosa cells. 
There was, however, a tendency towards a stimulation of P in granulosa cells 
during 2 h incubations. This tendency has been further analysed in two addi­
tional experiments on granulosa cells from human preovulatory follicles by 
prolonging the incubation time to 4 h. It was then found (Table V) that hCG 
elicited a statistically highly significant increase in P formation. It can 
be seen further from Table V that the basal amounts of P formed by the gra­
nulosa cells from the two follicles were markedly different. This presumably 
reflects differences in previous exposure to LH in vivo both with respect 
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to the amount and the time. The steroidogenically most active follicle 
(follicle A) was markedly protruding from the ovary and exhibited an ovu­
lation stigma, indicating that ovulation would have occured within few 
hours. 
Table V. Release of progesterone into the incubation medium during a 4 h 
incubation period of human granulosa cells from two preovulatory follicles. 
Progesterone release (ng/mg protein) 
control hCG 100 IU/ml significance 
follicle A 907.5 t 31.4 1270.4 - 69.2 (p < 0.001) 
(diam: 25 mm) 
follicle B 221.4 - 19.5 409.3 - 37.4 (p < 0.01) 
(diam: 23 mm) 
The follicles were obtained from different patients. Follicle A was estima­
ted to be within a few hours of ovulation. Values are given as means - SEM. 
It thus appears that human granulosa cells, as well as theca cells, 
from preovulatory follicles are capable of responding to hCG in vitro in 
terms of cAMP and P formation. 
Effects of hCG and prostaglandins on isolated corpora lutea of different 
ages (paper II). 
Prostaglandin E^ (as well as LH and hCG) has been shown to stimulate P 
synthesis in human CL (Marsh and LeMaire 1974, Nakashima 1979), while the 
role of PGF,^ in regulating the function of the human CL has been a matter 
of controversy. Several attempts to demonstrate a luteolytic effect of PGF_ 
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in vivo in the human have so far been unsuccessful (e.g. Jewelewicz et al 
1972, Kajanoja et al 1978). We have recently demonstrated that PGF„ in 
Za — 
vitro can counteract the stimulatory effect of hCG on cAMP formation in 
human CL of mid-luteal phase, indicating a role for PGF in the luteolytic 
process of the human (Hamberger et al 1979). 
In the present study (paper II) the effects of PGF„ and of PGE_ on the 
Za Z 
formation of cAMP and P were investigated, both alone and in combination 
with hCG, in human CL of different ages. It was clearly demonstrated that 
P^2a significantly counteracted the stimulatory effect of hCG on both cAMP 
and P formation in CL of mid-luteal phase, whereas in young and old CL, 
PGF„ did not interfere with the effects of hCG. PGE„, on the other hand, 
Za 2 
did not significantly alter the effect of hCG in CL of mid-luteal phase, 
while in young CL PGE^ potentiated the stimulatory effect of hCG on cAMP 
formation. Furthermore, PGE^, per se, caused a statistically significant 
increase in cAMP formation in young CL. In two additional experiments we 
also tested the effects of PGE^ on P formation in young CL. As seen from 
Table VI, PGE2 caused a slight, but insignificant increase in P production. 
The possibility that PGE^ stimulates the formation of other steroids more 
markedly remains to be settled. 
Table VI. Influence of PGE0 (1 yq/ml) alone and in combination with hCG 
(100 IU/ml) on progesterone release into the incubation medium during a 2 h 
incubation period of human CL of early luteal phase. 
Treatment Progesterone release (% of control value) 
control 100 - 11.1 
hCG 100 IU/ml 144.4 - 34.4 1 
PGE2 1 ug/ml 128.8 t 34.9 1 
hCG 100 IU/ml 
+ r 141.1 - 48.6 
PGE^ 1 yg/ml 
Results from two CL have been pooled and are expressed as means - SEM. 
1/ NS vs. control 
It can be concluded from this particular in vitro study that, while 
hCG has luteotropic effects in all CL up to 13 days of age, the effects of 
PGE^ and may be qualitatively opposite, depending on the age of the 
CL. In young CL PGE^ may have a luteotropic effect and in CL of mid-luteal 
phase PGF„ is luteolytic. 
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Steroid formation and effects of hCG in postmenopausal ovarian stromal tis­
sue (paper III). 
The ovarian stroma has been suggested to be a distinct gland of internal 
secretion within the ovary (Rice and Savard 1966). Several in vitro studies 
have shown that this compartment,in both the fertile and the postmenopausal 
ovary,has the capacity to produce androgenic steroids (e.g. Rice and Savard 
1966, Mattingly and Huang 1969). The stroma of postmenopausal ovaries has 
been claimed to be inactive in the aromatization of androgens to estrogens 
(Mattingly and Huang 1969). This concept is contradicted by the results of 
this study (paper III). It was found that specimens of "normal" atrophic 
stroma had the capacity to produce measurable amounts of E„, as well as P 
and A, in vitro. Furthermore, hyperplastic stroma from postmenopausal ova­
ries produced significantly higher amounts of in vitro than did atropic 
stroma. Also the production of A was considerably higher in ovaries with 
stromal hyperplasia, while P was formed in small and similar amounts by both 
stromal types. 
It was further found that hCG caused a statistically significant in­
crease in cAMP formation in hyperplastic stroma but not in atrophic stroma. 
These results indicate a preserved responsiveness to gonadotropin in post­
menopausal ovaries with stromal hyperplasia, although the steroid formation 
in vitro was not significantly altered by hCG during a 4 h incubation period. 
Thus it appears that the endocrine activity in postmenopausal ovarian 
stroma varies considerably from a relatively low capacity for steroid pro­
duction in atrophic stroma to a considerable degree of steroid formation and 
a clearcut aromatizing capacity in hyperplastic stroma. 
Steroid production and effects of hCG in postmenopausal ovarian hilus cells 
(paper IV). 
Since the ovarian hilus cells are irregularly distributed as small nests in 
the hilar region, these cells are difficult to identify morphologically. 
Therefore direct in vitro studies on the endocrine function of the hilus 
cells are lacking. There are, however, some indications that these cells are 
steroidogenically active: considerable activity in the hilus cells of cer­
tain oxidative enzymes generally associated with active steroidogenesis 
(Scully and Cohen 1964), and association between hyperplasia of the hilus 
cells and excess androgen production (Dennefors et al 1979). 
In the present study an attempt was made to identify hilus cells in 
specimens from the hilar tissue of postmenopausal ovaries and to study their 
endocrine activity in vitro. Strips of hilus tissue were carefully examined 
histologically by serial sectioning and typical hilus cell clusters were 
identified. When these tissue specimens were incubated for 4 h, measureable 
amounts of all three steroids were found. The pattern of steroidogenesis was 
similar to that of normal postmenopausal stroma with A being the predominant 
steroid formed. The absolute amounts of steroids produced by the hilus tis­
sue were, however, approx. 2-fold higher than those produced by normal stro­
ma when related to the protein content of the specimens (compare Fig 2, 
paper IV with Fig 3, paper III). Since the incubated specimens of hilus 
cells also contained protein from other, steroidogenically inactive struc-
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tures, this difference would probably be even more pronounced had the ste­
roid formation been related to the number of hilus and stromal cells. 
It was concluded that the hilus cells in human postmenopausal ovaries 
are steroidogenically active and that they may form a separate functional 
compartment of the ovary. 
It was further shown in paper IV that hCG elicited a statistically 
significant increase of cAMP formation after 30 min incubation and of P and 
E2 formation after 4 h incubation. It thus appears that the hilus cells from 
postmenopausal ovaries have a preserved responsiveness to hCG despite the 
fact that these cells are exposed continuously to elevated, endogenous LH-
levels in the circulation. 
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GENERAL DISCUSSION 
In this section the main findings of papers I - IV will be discussed 
in relation to relevant data from the literature. The emphasis will be on 
human studies with some necessary comparisons with animal experiments. The 
considerations will be given separately to each of the different compart­
ments of the ovary, although it must be kept in mind that these compartments 
are intimately linked to each other both morphologically and functio nally. 
Recent studies have shown that the various cell types of the human ovary 
can interact with each other to modify steroid production in vitro (McNatty 
et al 1980a, Batta et al 1980). 
In the last part of this section some possible clinical implications 
of the present and other related studies will be given. 
F o l l i c l e  
It is well established that almost all (99.9%) human follicles degenerate 
at various stages of development (Byskov 1978), most of them during early 
antral development (McNatty 1981). When studying human follicular function 
it is thus of crucial importance to determine whether a follicle is growing 
(i.e. has the potential for further development) or is atretic. Based on 
studies of human antral follicles McNatty and coworkers (1979b) have sug­
gested a series of parameters by which the degree of growth or atresia can 
be assessed. Growing follicles are characterized by: 1) more than 50% of 
the optimal number of granulosa cells corresponding to the follicular dia­
meter, 2) high concentrations of E(> 1000 ng/ml) in the follicular fluid 
or granulosa cells with the capacity to increase E^ synthesis in response 
to FSH, and, 3) a healthy looking germinal-vesicle stage oocyte. Atretic 
follicles are characterized by a relatively low number of granulosa cells 
(less than 50% of the full complement of granulosa cells for their respec­
tive diameter), by low concentrations of in the follicular fluid and by 
morphological signs of degeneration of the oocyte (McNatty et al 1979b). 
Other studies have confirmed the validity of these criteria for assessing 
a follicle as growing or atretic (McNatty 1979a, Hillier et al 1980). 
Atretic follicles: It has been shown that isolated cells from human atretic 
follicles produce mainly A and onl y small amounts of Eand P (McNatty et 
al 1979a, Dennefors and Nilsson, to be published). Therefore, these follic­
les have an androgen-enriched follicular fluid in which the mean level of A 
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is generally more than 30-fold higher than that of E? (McNatty et al 1979'3). 
In a recent study on intact human ovarian follicles explanted at term preg­
nancy, v/e found t hat these follicles, which all showed histological signs 
of atresia, secreted large amounts of A and small amounts of P and E^ during 
short term incubations (Dennefors and Nilsson 1981). 
Growing follicles: Although the fate of most follicles is to undergo atresia, 
at least one follicle is selected for further development and ovulation in 
every normal cycle. The mechanism of action underlying this selection is 
still an enigma, although it appears that the hormonal environment within 
the follicle is one key factor in determining its subseguent development. 
Since only follicles with an "estrogenic" microenvironment have the poten­
tial for further growth it has been suggested that the development of a 
functional aromatase enzyme system in the follicle during early follicular 
growth is of crucial importance for continuation of growth (McNatty 1981). 
When a certain follicle has been selected for further development, it 
enlarges and accumulates large numbers of granulosa cells, substantial theca 
mass and increasing amounts of follicular fluid. As a conseguence, the 
follicle becomes more active steroidogenically. 
During the early and mid-follicular phases, the ovary secretes increa­
sing amounts of E^ and, to a lesser extent, A. The thecal tissue of growing, 
not fully developed follicles has been found to produce mainly A and small 
amounts of estrogens and P in vitro (Mc Natty et al 1979a). Consequently the 
granulosa cells have been claimed to be the major source of estrogen produc­
tion in these follicles. Moon and coworkers (1978) found that human granu­
losa cells of growing follicles produced little or no estrogen in culture 
unless testosterone was added as a substrate. On the other hand, McNatty et 
al (1979a), using a similar experimental system, reported that granulosa 
cells from growing follicles cultured without precursors produced conside­
rable amounts of and smaTl amounts of A and P. Although this discrepancy 
is difficult to explain, it may well be due to differing amounts of precur­
sors present in the serum-enriched culture media, or to varying stages of 
development of the follicles studied. Nevertheless, the results from these 
two studies concur in that human granulosa cells from growing follicles 
have an aromatizing capacity. This has been confirmed by Erickson and co­
workers (1979) who also demonstrated that granulosa cells from human fol­
licles achieve a functional aromatase system when the follicle has reached 
a certain stage of development (6-8 mm in diameter), furthermore, numerous 
studies from various animal species on isolated granulosa cells in culture 
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have provided direct biochemical data that granulosa cells can convert and­
rogens to estrogens but have low capacity to synthesize androgens from 
pregnenolone or progesterone (for refs see Richards 1980). Taken together 
with the findings that the theca is the major source of androgens, these 
data support the "two-cell" hypothesis for ovarian estrogen secretion ori­
ginally proposed by Falck (1959) and subsequently modified by Armstrong and 
Dorrington (1977). This hypothesis states that androgens produced by the 
theca cells diffuse to and are aromatized by the granulosa cells. 
The steroidogenesis in the growing follicle is regulated by both LH 
and FSH. It has been shown that human theca cells are responsive to LH/hCG, 
but not to FSH, in terms of cAMP and steroid formation (Tsang et al 1979, 
McNatty et al 1980 , Dennefors and Nilsson, to be published),and receptors 
for LH/hCG have been demonstrated on the theca cells of pig and rat follic­
les (Rajanierni and Vanha Pe rttula 1972, Channing and Kammerman 1974). FSH, 
but not LH/hCG, has been found to stimulate the aromatase activity of human 
granulosa cells in vitro (Moon et al 1978, Erickson et al 1979, Hillier et 
al 1980) and, further, FSH receptors have been located on the granulosa 
cells in the rat (Midgley et al 1974, Richards et al 1976). Thus, during 
follicular development, FSH plays an important role in stimulating the 
aromatization of androgens by the granulosa cells, thereby sustaining a 
follicular "estrogenic" microenvironment, which, according to the above 
mentioned theory, is a prerequisite for further development into a pre­
ovulatory follicle. 
Preovulatory follicles: When the follicle reaches its final phase of matura­
tion it has accumulated most of its granulosa and theca cells. However, the 
follicle continues to grow during the preovulatory period and this enlarge­
ment (from approx. 12 to 25-30 mm in diameter) is due almost entirely to 
accumulation of follicular fluid (McNatty 1981). This large preovulatory 
follicle is steroidogenically more active than any other follicle in the 
ovary and is the major source of estrogen production (Baird and Fraser 1974, 
Richards 1980). 
There have been relatively few studies on the steroidogenic capacity 
of the theca cells from human preovulatory follicles, probably due to diffi­
culties in obtaining a theca cell preparation free from contaminating gra­
nulosa cells. McNatty and coworkers (1979a) reported, in a study on a small 
number of human preovulatory follicles, that the thecal tissue from these 
follicles secreted mainly A, but also some P and in culture. Evidence 
that the theca is the major follicular source of androgens has also been 
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obtained from studies in different animal species (for refs see Richards 
1980). The results of the present study (paper I) demonstrate that acutely 
incubated theca cells from preovulatory follicles produce A as the dominant 
steroid and that, in addition, considerable amounts of E^, and some P, are 
produced as well. This pattern of steroidogenesis in the theca cells of 
preovulatory follicles is similar to that of less developed follicles (see 
above), but the relative amount of Eformed is higher when the follicle is 
preovulatory. 
The preovulatory granulosa cells of the present study had the capacity 
to produce all three steroids measured in vitro. The major steroid formed 
was P, but considerable amounts of E2 were also produced. These data are 
in agreement with the results of McNatty and coworkers (1979a) who found a 
similar pattern of steroidogenesis in cultured granulosa cells from large, 
human follicles. 
The validity of the "two cell" theory for estrogen secretion in the 
preovulatory follicle has been a matter of debate. For instance, Channing 
and Coudert (1976) reported that estrogen secretion was maintained after 
the aspiration of granulosa cells from monkey preovulatory follicles in vivo, 
indicating that the theca itself is able to synthesize E . The results of 
the present study strongly indicate that steroidogenesis in the human pre­
ovulatory follicle is not rigidly compartmentalized, but they do not comp­
letely oppose the "two-cell" theory. Since the patterns of steroidogenesis 
in the two cell types of the preovulatory follicle are different from one 
another, a certain degree of collaboration between the two cell types in 
modifying the steroid output of the follicle may exist in vivo. This concept 
is further strengthened by the finding of McNatty and coworkers (1980a) that 
recombination of isolated granulosa and theca cells from large human follic­
les caused a synergistic production of P and E^ after 48 h of co-culture 
(for E^ only in the presence of LH and FSH). 
It thus seems clear, that when the follicle develops into a preovula­
tory structure, its granulosa cells change steroid production from predomi­
nantly E2 to predominantly P. This shift in granulosa cell steroidogenesis 
is reflected in changes in antral fluid steroid concentrations. During the 
late follicular phase, the levels of estrogens in antral fluid decline, and 
those of P strongly increase (McNatty 1978). These changes in granulosa cell 
function are most, likely regulated by endogenous gonadotropins. 
In paper I it was shown that hCG stimulated cAMP and steroid formation 
in preovulatory theca cells, and this is in agreement with the few other 
human studies which have reported a similar stimulatory effect of LH/hCG on 
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theca cells from follicles of various stages of development (Tsang et al 
1979, McNatty 1980^). Furthermore, receptors for LH/hCG have been demonstra­
ted on the theca cells of pig and rat follicles (Rajaniemi and Vanha- Ffertulla 
1972 , Channing and Kammerman 1974). FSH, on the other hand, has been found 
to have no effect on human theca cells as judged by cAMP and steroid forma­
tion (Tsang et al 1979). Thus, it may be concluded that steroidogenesis in 
human theca cells of mature follicles is regulated exclusively by LH. 
As mentioned earlier, granulosa cells possess receptors for FSH and 
this hormone has been found to stimulate the aromatase enzyme system in 
human granulosa cells from growing follicles. LH/hCG, on the other hand, 
has no effects on these immature granulosa cells as judged from cAMP and 
steroid formation (Noon et al 1978, Tsang et al 1979, Hillier et al 1980). 
This coincides with the findings in the rat that functional receptors for 
LH/hCG are located on granulosa cells from large, preovulatory follicles but 
not from follicles in earlier stages of development (Zeleznik et al 1974). 
It has recently been shown that follicular maturation in the human is asso­
ciated with an increase in the number of LH/hCG receptors on the granulosa 
cells (Rajaniemi et al 1981). In paper I, a clearcut stimulation of cAMP 
formation by hCG w as demonstrated in the granulosa cells from preovulatory 
follicles and, in two additional experiments, a significant increase in P 
production in response to hCG was found (Table V, p.29). Although this acute 
stimulatory effect of hCG on granulosa cells from preovulatory follicles is 
in agreement with the above mentioned receptor findings, it has never pre­
viously been demonstrated in the human. This could be due to the fact that 
only granulosa cells from truly preovulatory follicles can respond to LH/hCG. 
Prolonged influence of LH in vivo has been reported to induce a block in the 
formation of A in both granulosa and theca cells from rat preovulatory fol­
licles, thereby causing a shift in steroidogenesis of the whole follicle 
from E2 towards P formation (Hamberger et al 1978). The above findings in 
isolated human granulosa cells might indicate the existence of a similar 
mechanism in the primate. 
Thus, when the follicle has reached full maturation its granulosa cells 
have achieved a responsiveness to LH/hCG, probably as a result of a stimu­
latory effect on these cells by increasing follicular levels of FSH and E^ 
(Zeleznik et al 1974, Channing 1975). This achieved responsiveness to LH 
of the granulosa cells concomitant with the endogenous LH surge appears to 
have important implications: 1) inhibition of further granulosa cell pro­
liferation (Delforge et al 1972, Rao et al 1978) and 2) shift from estrogen 
to progesterone secretion and luteinization. 
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After ovulation, the preovulatory follicle is transformed into another 
ovarian compartment, the CL. However, the ultimate fate of all the atretic 
follicles is less clear but, sooner or later, they disappear into, or pos­
sibly form a part of, the ovarian stroma (Mossman et al 1964). 
C o r p u s  l u t e u m  
When the CL is formed the luteinized granulosa cells, which form the major 
proportion of the CL, are producing considerable amounts of P. This is the 
dominant steroid secreted by the ovary during the luteal phase. Estrogens 
also are produced by the human CL, and this is a unique feature for the 
primate CL (Savard et al 1965, Baird and Fraser 1974, Challis et al 1976). 
In vivo studies have shown that approx. 95% of the production of by the 
human ovary during the luteal phase originates from the C.L (Baird and Fraser 
1974). From direct studies on the concentration of steroids in the human CL 
(Challis et al 1976, Patwardhan and Lanthier 1980) and from short term in­
cubations (Nakashima 1979, Dennefors, unpublished observations) it can be 
estimated on a molar basis that the total production of P is approx. 20-50 
fold higher than that of E^ during the life span of the CL. The results of 
the present study (paper II) show that the amounts of P produced per mg pro­
tein by newly formed CL are 3-4 fold lower than those formed by mid-luteal 
phase CL, and of the same magnitude as those produced by late luteal phase 
CL. Since these in vitro data are in good agreement with the dynamics in P 
secretion by the CL in vivo, they contradict the concept that it is princi­
pally the increase in CL mass which accounts for the progressive increase 
in P secretion during the early and mid-luteal phase (Armstrong and Black 
1966). Furthermore, the production of E by the CL appears to change during 
the luteal phase, with the highest amounts of E^ formed in mid-luteal phase 
(Swanston et al 1977). 
The life span and function of the CL appear to be regulated by a comp­
lex system of intrinsic and extrinsic stimulatory (luteotropic) and inhibi­
tory (luteolytic) factors. Corpora lutea induced in hypophysectomized women 
by treatment with FSH and LH will function for about 3-4 days without any 
further treatment (Vande Wiele et al 1970). This finding indicates that, 
although the human CL is autonomous to a certain extent, it needs continuous 
support of LH for its normal function. LH, or hCG during pregnancy, appears 
to be the major extrinsic luteotropin in the human, and has been shown to 
stimulate both cAMP (Marsh and LeMaire 1972) and P production (Rice.et al 
1964, Hanson et al 1971) in the human CL. Also in the present study, a 
stimulatory effect of hCG on both cAMP and P formation was noted in CL up 
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to 13 days of age (paper II). The responsiveness to hCG was most pronounced 
in CL of the mid-luteal phase. In an earlier study, using the same in vitro 
system, we have shown that the sensitivity to hCG of human CL declines at 
the time around the menstruation (14 - 15 days after ovulation) (Hamberger 
et al 1979). This apparently rather abrupt decline in gonadotropin sensiti­
vity may be due, at least partly, to a loss of gonadotropin receptors (Conti 
et al 1977, McNeilly et al 1980). 
Prolactin is an important luteotropic hormone in several animal species 
e.g. the rat (for refs see Rothch'ild 1981 ), McNatty and coworkers (1974) 
have reported that the production of P by human luteinized granulosa cells 
in culture requires low concentrations of prolactin, indicating that this 
hormone has either a true or a permissive luteotropic effect also in the 
human. Hyperprolactinemia, on the other hand, is associated with short lu­
teal phase and reduction in P secretion in the human (Schneider et al 1977). 
The precise role of prolactin in regulating the human CL is unclear to date 
and has not been investigated in the present study. 
In addition to these extrinsic luteotropins, hormones produced within 
the CL may possess luteotropic effects. One such hormone is PGE^, which is 
synthesized by the human CL (Challis et al 1976) and which has been shown 
to stimulate cAMP and P formation in human CL of non classified ages in 
vitro (Marsh and LeMaire 1974). In the present study it was found that PGE? 
stimulated cAMP formation in young CL but not in CL of mid-luteal phase. In 
two additional experiments performed on young CL a weak but non significant 
increase .in P production was found (Table VI, p. 30). Although not conclu­
sive, these data indicate that PGE„ might have a luteotropic effect in the 
newly formed human CL. 
Interestingly, P itself has been suggested as an intrinsic luteotropin 
by Rothchild (1981). The strongest support for the suggestion that P pro­
motes its own secretion is the direct relationship between intraluteal P 
concentration and the rate of P secretion, which is in contrast to the lack 
of relation between P secretion by t he CL of the c\cle and that of its 
presumed extrinsic stimulus (LH) (Rothchild 1981). The hypothesis that P 
stimulates its own secretion may explain why the CL can function autonomous­
ly for a limited time (see above). 
There is overwhelming evidence that uterine PGF9 is the physiological 
luteolysin in the sheep (for review see Horton and Poyser 1976). In many 
other species (e.g. rabbits, rats, cows, pigs, horses) PGF„ can induce 
Za 
luteolysis (Horton and Poyser 1976), although a uterine production of PGF„ 
za 
is not of essential importance in all species. It is well known, however, 
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that PGF-;^ is produced by the CL, both in animals (Demers et al 1973) and in 
the human (Challis et al 1976), indicating that PGF^ may be an intrinsic 
luteolytic factor. There is so far no conclusive evidence for a luteolytic 
effect of PGF„ in vivo in the human, but this could solely be due to the 
za  
inability to reach adequate local ovarian concentrations of PGF„ when the 
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compound is given systemically. By injecting very high doses of PGF2a via 
laparoscopy directly into the human CL, Korda and coworkers (1975) could 
demonstrate a profound fall in plasma P levels which was followed by a 
menstrual like bleeding. Similar experiments have recently been performed 
in the rhesus monkey using continuous infusions of lower doses of PGF^ 
(Auletta et al 1981). It was then found that intraluteal PGF„ induced func-
z a 
tional luteolysis in this species. 
In 1975, McNatty and coworkers demonstrated a "luteolytic" effect of 
PGF„ in vitro on human luteinized granulosa cells in culture. Four years 
Za  
later we showed that PGF„ in vitro could counteract the stimulatory effect 
Za • • 
of hCG on cAMP formation in human CL of mid-luteal phase (Hamberger et al 
1979). In the present study on isolated human CL of well defined ages, PGF^ 
significantly inhibited the stimulatory effect of hCG on both cAMP and P 
formation in mid-luteal phase CL. Although PGF£ had no effect per se, these 
data strongly indicate that PGF^ can cause luteolysis by possessing an anti-
gonadotropic effect. The concept that PGF^ is a physiologic luteolytic 
hormone in the human is strengthened by the finding that human CL possess 
receptors for PGF^ (Powell et al 1974), and that these receptors have many 
characteristics similar to those found in bovine CL (Rao et al 1977), where 
PGF^ undoubtedly is luteolytic. 
The reason why PGF^ has an antigonadotropic effect only in CL of the 
mid-luteal phase, and not in young or old CL, has been explored in another 
series of experiments in our laboratory. In the newly formed PMSG induced 
CL of the rat, blood flow is extremely high (Damber et al 1981). The maxi­
mally dilated vessels are devoid of innervation at this early stage. When 
the rat CL is five to eight days of age, a norepinephrine (NE) innervation 
of the vessels appears concomitant with a slight decrease in CL blood flow, 
probably due to an increased vascular tonus, and with the appearance of a 
maximal interaction between LH/hCG and PGF2a (Hamberger et al 1980). A simi­
lar situation appears to exist in women. These findings indicate that the 
endogenous amounts of NE in the CL are of importance in modifying the effects 
of PGF^. This hypothesis was tested in the human by adding NE to incubated 
specimens of young CL. It was then found that PGF^ counteracted the stimu­
latory effect of hCG on cAMP formation also in these young CL. Furthermore, 
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when reserpine was added to incubated mid-luteal phase CL (to deplete the 
specimens of cathecolamines), the antigonadotropic effect of PGFg^ was ab­
sent (Hamberger et al 1980). These data thus suggest that vascular innerva­
tion is a prerequisite for PG-induced luteolysis in the human. If this 
theory proves correct it can also explain why attempts to demonstrate a 
luteolytic effect of dispersed human luteal cells have been un­
successful (e.g. Richardson and Masson 1980). Tissue integrity seems to be 
of essential importance,at least when it concerns the human CL. The fact 
that exerted its luteolytic effect in an in vitro system indicates 
that the compound does not act directly on blood flow. This concept is in 
agreement with recent animal data (Pang and Behrman 1979, Damber et al 1981). 
Estrogens have been implicated in the luteolytic process in the human, 
since it has been shown that administration of estrogens in vivo to women 
in the postovulatory phase of the normal cycle can cause luteolysis (Hoffman 
1960, Johansson and Gemzell 1971, Gore et al 1973), and that E^ in vitro 
can inhibit the stimulatory effect of hCG on P synthesis in isolated human 
luteal cells (Williams et al 1979). It is at present unclear whether E^ has 
a direct luteolytic effect on the human CL or acts indirectly via intra-
luteal PGF^, as has been suggested by Auletta and coworkers (1978) in their 
report on primate experiments. In a recent in vitro study on dispersed human 
luteal cells the addition of indomethacin did not prevent the inhibitory 
effect of on hCG stimulated P accumulation, although the accumulation of 
PGF„ was markedly reduced (Thibier et al 1980). 
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O v a r i a n  s t r o m a  
The biochemistry of the stromal elements of the ovary has not been studied 
to the same extent as that of the follicle or the CL. As mentioned earlier, 
Rice and Savard (1966) were the first to report that the stroma from human 
ovaries, obtained at different phases of the menstrual cycle or during 
pregnancy, is capable of producing androgenic steroids in vitro. More recent­
ly,McNatty and coworkers (1979a) demonstrated that the ovarian stroma from 
women at different phases of the menstrual cycle had the capacity to produce 
P, androgens and estrogens during tissue culture. The relative amounts of 
steroids produced by the stroma varied with the phase of the menstrual cycle, 
the highest amounts being found during the late follicular phase, probably 
due to a previous exposure to gonadotropins in vivo. Androstenedione was 
the major steroid formed in vitro at all stages of the menstrual cycle, 
despite P being formed in similar amounts to A during the late follicular 
phase. The stromal production of estrogens in vitro was low at all phases 
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of the cycle. 
Mattingly and Huang (1969) reported that the stroma from postmenopausal 
ovaries also can produce androgens in vitro. Since only trace amounts of 
estrogens were formed in their study, these authors concluded that the post­
menopausal stroma is inactive in the aromatization of androgens to estrogens. 
However, later in vivo studies have shown significantly higher amounts of 
E2 in ovarian vein blood when compared to peripheral vein blood in post­
menopausal women (Judd et al 1974, Greenblatt et al 1976), indicating a 
certain, although probably limited, aromatazing capacity of the postmeno­
pausal ovary. These latter findings are more in accordance with'the results 
of the present study which show that stromal tissue from postmenopausal 
ovaries can form E^ in vitro. 
Around and after the menopause the ovarian stroma often shows signs of 
moderate to marked proliferation, with the highest incidence (36%) occurring 
between 56 - 70 years of age (Boss et al 1965). Therefore, it has been 
hypothesized that the high endogenous gonadotropins in the postmenopausal 
period may induce stromal hyperplasia (Boss et al 1965). This hypothesis is 
now further supported by the finding from the present study that only speci­
mens with clear stromal hyperplasia can respond to hCG in terms of increased 
cAMP formation, demonstrating a preserved gonadotropic responsiveness in 
these ovaries. Hyperplastic stroma reacted differently from atrophic stroma 
in yet another way. The basal production of A and E^ was more than two-fold 
higher in hyperplastic than in atrophic stroma, this higher production of 
E^ by hy perplastic stroma is especially interesting in view of the possible 
association between stromal hyperplasia and endometrial carcinoma, as dis­
cussed below. Only cases with clear signs of stromal hyperplasia (as defined 
in paper III) were included in the group of hyperplasia. Thus the separation 
of the hyperplastic group from the atrophic group was morphologically dis­
tinct (Eig 1 and 2, paper III). However, it must be emphasized that stromal 
hyperplasia is a condition where the borderline between -the normal and 
pathologic states cannot be readily distinguished. The results of the pre­
sent study indicate that the cell types within the hyperplastic stroma may 
be of greater significance for functional activity than the actual guantity 
of hyperplastic stroma. There are also indications that the process of 
hyperplasia is reversible (Boss et al 1965). 
It thus appears from the present and other studies that the stroma of 
the human ovary is a distinct functional compartment producing mainly andro­
gens. After the menopause, when the stroma forms the major part of the ovary, 
this compartment may become more or less hyperplastic, probably due to 
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gonadotropic stimulation, with consequently increased secretion of A a nd 
E„ by the ovary. The variability of the endocrine activity in the postmeno­
pausal ovary has recently been demo nstrated by Longcope et al (1980), who 
measured the concentration of steroids in ovarian arterial and venou s blood 
in a large number of postmenopausal women. The steroid levels varied markedly 
between different women, but in 30% of the patients considerably higher 
levels of and A were f ound in venous as compared to arterial blood. This 
increased ovarian steroid production in some of the patients could have been 
caused by str omal hyperplasia in the ovaries. Another possible source of 
increased steroid production could be the hilus tissue. 
H i l u s  c e l l s  
Nests of hilus cells can be found microscopically in the ovarian hilus of 
probably all adult ovaries, but the number of hilus cells varies considerably 
between different women (Sternberg 1949). These cells are particularly pro­
minent during pregnancy, and during and after the menopause, probably due to 
influence of gonadotropins (Sternberg 1949, Boss et al 1965). Histochemical 
studies have demonstrated strong activity of certain oxidative enzymes, 
associated with active steroidogenesis, in the hilus cells (Scully and Cohen 
1964). S ince the hilus cells are morphologically identical with testicular 
Leydig cells, and since hilus cell hyperplasia and tumors are often associa­
ted with virilization, these cells have been claimed to secrete androgens 
(Sternberg 1949). 
In the present study (paper IV) specimens from the hilar tissue of 
postmenopausal ovaries were isolated and found to contain typical hilus 
cells. When these specimens were incubated, a similar pattern of steroido­
genesis as in atrophic stroma was demonstrated, with A bein g the major ste­
roid formed. These data therefore confirm that the hilus cells from post­
menopausal ovaries are steroidogenically active producing mainly androgens. 
Since the hilus cells are embryologically and histologically different from 
the stroma cells, it is reasonable to suggest that the hilus cells form an 
additional functional compartment of the human ovary. 
In the present study the amounts of steroids formed in vitro were con­
siderably higher in hilus cells than in stromal cells when related to tissue 
protein content (p. 31). It must be remembered, however, that the total mass 
of stroma is much higher than that of hilus cells in the postmenopausal 
ovary. Therefore, the hilus cells probably contribute to only a small por­
tion of the total steroid output of the postmenopausal ovary in the physio­
logical situation. 
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Earlier studies have shown that the hilus cells of both fertile and 
postmenopausal ovaries can respond to hCG in vivo as judged by morphological 
changes of the cells (Sternberg et al 1953) and histochemical evidence of 
stimulation (Poliak et al 1968). This statement is confirmed more directly 
by the results of the present in vitro study, which clearly demonstrate that 
the hilus cells can respond to hCG with increased cAMP and steroid formation. 
Of particular interest is the marked increase in production in view of 
the high endogenous levels of LH during the postmenopausal period. The hilus 
cells could be a potential source of estrogen production in the postmeno­
pausal ovary. In women with a large number of hilus cells, this compartment 
may be of both physiological and clinical importance. 
C l i n i c a l  i m p l i c a t i o n s  
In paper I it was demonstrated that human preovulatory follicles may reach 
a diameter up to at least 25-30 mm. This implies that so called "follicular 
cysts" of such a size should not be resected routinely during laparotomy of 
young women, since these "cysts" are most likely normal preovulatory follic­
les. This statement does not, of course, apply to small ovarian cysts with 
suspicious signs of neoplasia or endometriosis. 
In the previous section a seguence of hormonal changes crucial for nor­
mal follicular development has been described. In short, this development 
reguires a certain "threshold"level of FSH during the early and mid-folli-
cular phases to stimulate the granulosa cells for conversion of androgens 
to estrogens, thereby generating an estrogen-enriched environment within the 
follicle. When the follicle is fully mature (preovulatory) both granulosa 
and theca cells are responsive to LH. The preovulatory levels of LH arrest 
further granulosa cell proliferation and induce luteinization of the fol­
licle. Based on this precise seguence of FSH and LH release in vivo, some 
important implications concerning the treatment of anovulatory women with 
exogenous gonadotropins can be drawn. These gonadotropins should ideally be 
given in a schedule imitating the normal in vivo situation and, therefore, 
daily estimations of estrogens in urine, or preferably blood, are necessary. 
In the early and rnid-follicular phases exogenous FSH must be given in amounts 
great enough to stimulate the aromatizing capacity of the granulosa cells, 
thereby avoiding accumulation of large concentrations of androgens in the 
follicular fluid. Another crucial point is to give LH or hCG at exactly the 
right time. If LH is given too early (i.e. before the granulosa cells are 
mature enough to respond fully to LH), LH blocks granulosa cell mitoses and 
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stimulates the theca cells to increased androgen production, the latter 
leading to increasing amounts of androgens in the follicular fluid. Since 
the granulosa cells are no longer capable of converting these androgens to 
estrogens, an androgen-enriched environment within the follicle will be 
generated, with the consequence that the follicle goes into irreversible 
atresia. Such a paradoxical action of hCG, when administered prematurely 
during the late follicular phase, has recently been demonstrated in monkeys 
(Williams and Hodgen 1980). 
In the last 10 years several studies have clarified some of the patho­
physiologic events of the polycystic ovary syndrome (PCO), although its 
primary causes have not been defined. This syndrome is characterized by 
the presence of multiple, medium sized ovarian follicles (2-6 rnm in diame­
ter). It has been shown that these follicles contain high concentrations of 
A and very s mall amounts of E^  or estrone in their follicular fluid, indi­
cating a deficient aromatase enzyme activity in the granulosa cells (Short 
and London 1961). However, since the normal growing human follicle does not 
aquire an effective aromatase system until it has reached a diameter of 
6-8 mm (Erickson et al 1979), these findings in the PCO follicles are actual­
ly not abnormal. Studies of isolated granulosa and theca cells derived from 
follicles of normal and PCO ovaries have shown, that these cells, from both 
types of ovaries, have a similar capacity to produce steroids in vitro, and 
further, that the granulosa cells from PCO follicles can respond to FSH 
with increased estrogen secretion both in vivo and in vitro (Erickson et al 
1979, Wilson et al 1979). These findings suggest that the absence of aroma­
tase activity in the granulosa cells from patients with PCO is caused by an 
inappropriate stimulation of the ovaries by FSH, and not by an inherent 
defect in the follicular cells (Erickson et al 1979). 
The stromal compartment also has been suggested to be involved in the 
pathophysiology of PCO (Yen 1980). Rice and Savard (1966) studied the in 
vitro steroid formation in stroma from patients with PCO comparing it to 
normal stroma from patients of various phases of the cycle. They found that 
the spectrum of steroids formed in vitro was strikingly similar between the 
two groups. The absolute amounts of steroids formed (as judged from incor­
poration of radiolabelled acetate) were, however, considerably higher in the 
stroma from PCO patients than in normal, mid-follicular phase stroma, and 
were of the same magnitude as the amounts formed by normal stroma from the 
late follicular phase. Based on these findings, the authors suggested that 
the high amounts of steroids (mainly androgens) produced by the stroma in 
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patients with PCO are merely an effect of persistent and high levels of 
endogenous gonadotropins (Rice and Savard 1966). 
Although the causes and pathogenesis of PCO are still obscure, it ap­
pears that the endocrine changes noted in the ovaries of this disease are 
the results of an abnormal gonadotropic influence, and are not caused by a 
primary defect in ovarian steroidogenesis. 
Numerous publications during the past three decades have discussed the 
alleged relationship of ovarian stromal hyperplasia to endometrial carcinoma. 
A significantly higher percentage of stromal hyperplasia in the ovaries of 
women with this type of cancer as compared to postmortem control specimens 
has been reported by many groups (e.g. Woll et al 1948, Novak and Möhler 
1953). However, investigations comparing ovaries obtained at operation with 
postmortem control ovaries can be critized. Other authors, which have used 
surgical specimens as controls, have not found any consistent changes in 
the ovaries of patients with endometrial hyperplasia or endometrial carci­
noma (e.g. Roddick and Greene 1957, Bigelow 1958). 
It is generally agreed that prolonged, unopposed administration of exo­
genous estrogens can produce endometrial hyperplasia and cancer. Whether or 
not endogenous estrogens are involved in the pathogenesis of endometrial 
carcinoma is less clear. Some studies in postmenopausal women with endo­
metrial cancer or hyperplasia have reported an elevated urinary estrogen 
excretion when compared to postmenopausal control subjects (Rome et al 1977, 
Reti et al 1978), while in other studies no differences in estrogen excre­
tion were found between these two groups (Charles et al 1965, Procopé 1968). 
Both Judd and coworkers (1976) and Calanog and coworkers (1977) measured 
serum levels of E^ and estrone in postmenopausal women with and without 
endometrial cancer. No statistically significant differences were found 
between the mean values of and estrone in these two studies. It is, how­
ever, noteworthy that the individual serum levels of E^ and estrone in some 
of the cancer patients were clearly higher than in the control groups, in 
both studies, furthermore, in Calanog's study significantly higher serum 
levels of A were found in the cancer group when compared to the control 
group. It is well documented that circulating A can be co nverted to estrone 
in peripheral tissues, such as fat and muscle, and this conversion rate has 
been claimed to increase with age (Hemsell et al 1974). In addition, seve­
ral in vivo investigations have shown that the peripheral conversion of A 
to estrone is significantly higher (approx. two-fold) in patients with 
endometrial cancer than in non-cancer controls (Hausknecht and Gusberg 1973, 
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Siiteri and McDonald 1973, Calanog et al 1977). This difference has been 
claimed, however, to be due mainly to a higher incidence of obesity in the 
cancer group (Rizkallah et al 1975). On the other hand, Schindler et al 
(1972) and Forney et al (1981) demonstrated that the peripheral conversion 
of A to estrone by human fat tissue in vitro was significantly higher in 
patients with endometrial cancer than in healthy controls. 
The results of the present study (paper III), demonstrating an increa­
sed androgen and estrogen production in postmenopausal ovaries with stromal 
hyperplasia, contribute to the discussion of the causual relationship be­
tween stromal hyperplasia, increased estrogen production and endometrial 
cancer. Based on the above mentioned studies and the present study it is 
suggested that ovaries with stromal hyperplasia may play a role in the 
pathogenesis of endometrial cancer in some postmenopausal women,by producing 
substantial amounts of estrogens, both directly and indirectly via peri­
pheral conversion of ovarian androgens,.' This increased production of estro­
gens in vivo is probably more pronounced if the patient has stromal hyper­
plasia and is obese, a combination which is not unusual according to Boss 
and coworkers (1965). 
Ovarian stromal hyperplasia can also have other clinical implications. 
Boss and coworkers (1965) found a correlation between moderate to marked 
stromal hyperplasia and varying degrees of virilization in postmenopausal 
women. This correlation is especially strong when abundant theca-lutein-like 
cells occur in the hyperplastic stroma (hyperthecosis), and such ovaries 
have been shown to produce several fold more androgens than normal ovaries 
in both postmenopausal and younger women with signs of virilization (Aiman 
et al 1978, Braithwaite et al 1978). The results of the present study support 
the concept that stromal hyperplasia can cause hirsutism and varying degrees 
of virilization in postmenopausal women,by increased ovarian androgen pro­
duction. 
Boss and coworkers (1965) have observed a strong positive correlation 
between the degree of stromal hyperplasia and the number of hilus cells in 
postmenopausal women. Since, in the present study, the hilus cells were 
found to produce A and in amounts even higher than those of hyperplastic 
stromal cells, it seems reasonable to conclude that the combination of 
marked stromal hyperplasia and numerous hilus cells in the postmenopausal 
ovary is unfavourable and may aggravate the above mentioned clinical con-
seguences. 
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Hilus cell hyperplasia is often associated with clinical signs of viri­
lization (Sternberg 1949). Recently, we studied the steroid production by 
the ovaries from a markedly virilized postmenopausal woman. Her serum testo­
sterone was approx. 20 nmol/1 in repeated determinations (normal range 
1-4 nmol/1) and both ovaries showed a marked nodular hilus cell hyperplasia, 
not only in the hilus region but also in the cortical stroma. When specimens 
from these ovaries were incubated for 2 h with and without hCG (60 IU/ml) 
high amounts of A were released into the incubation medium (Fig. 2). There 
was also a marked responsiveness to hCG in terms of cAMP formation (Fig. 3), 
this increase in cAMP being much higher than in normal hilus cells (compare 
Fig. 3 with Fig. 1, paper IV). 
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Fig. 2. Release of steroids into 
the incubation medium from ovarian 
specimens showing marked hilus 
cell hyperplasia. Incubation pe­
riod was 2 h; see text for further 
details. 
Bars indicate means and vertical 
lines - SEM. 
The stimulatory effects of hCG on 
the release of P and are sta­
tistically significant (p < 0.05). 
Fig. 3. Tissue formation of cAMP in 
ovarian specimens with marked hilus 
cell hyperplasia. Same patient as in 
Fig. 2. 
Bars indicate means and vertical 
lines p SEM. 
The stimulatory effect of hCG is 
highly significant (p < 0.001). 
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The similarity between stromal hyperplasia and hilus cell hyperplasia 
in this respect is obvious and it seems most probable that both disorders 
are caused by a preserved responsiveness to gonadotropins after the meno­
pause. It remains unclear whether this is due to gonadotropic receptors 
still present on the cells or to intracellular mechanisms. Future receptor 
studies of human postmenopausal ovaries may give more insight in the func­
tional Variability of the human postmenopausal ovary. 
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GENERAL SUMMARY 
Cells from different compartments of the human ovary were isolated, 
characterized and utilized for investigations of gonadotropic influence on 
cAMP formation and steroidogenesis in short-time incubations (30-240 min). 
In addition, the influence of PG:s on specimens from CL of different ages 
were studied. 
1) Preovulatory follicles: All follicles were carefully examined to assess 
their degree of development. The two main cell types constituting the fol­
licle, granulosa and theca cells, were mechanically isolated and incubated 
separately. Both these cell types had the capacity to form all three steroids 
measured (P, A, E^). The major steroid formed was A for theca cells and P 
for granulosa cells, while E2 was formed in appreciable amounts by b oth 
cell types. The results strongly indicate that steroidogenesis is not strict­
ly compartmentalized in the human preovulatory follicle. 
Both follicular cell types responded to varying concentrations of hCG 
with a concentration-dependent increase in cAMP formation. Also the produc­
tion of P and A by the theca cells, and P by the granulosa cells, was signi­
ficantly stimulated by hC G in vitro. These data demonstrate that both cell 
types in the preovulatory follicle are acutely responsive to hCG. 
2) Corpus luteum: Specimens from CL, dated precisely in relation to the time 
for ovulation, were incubated and the effects of PGE£ and PGp2a, alone and 
in combination with hCG, on cAMP and P formation were studied. Human CG 
stimulated cAMP formation and tended to increase P production in young and 
old CL. The strongest effects of hCG were noted in CL of the mid-luteal 
phase, where the formation of both cAMP and P was stimulated. PGE^. exhibited 
a stimulatory effect on cAMP formation, both directly and by p otentiation 
of the effect of hCG, albeit only in newly formed CL. PGE^^, on the other 
hand, significantly counteracted the stimulatory effect of hCG on both cAMP 
and P formation in CL of the rnid-luteal phase. In young and old CL PGE^, 
per se, had no effect on cAMP or P formation, and did not interfere with 
the effects of hCG. These results indicate that PGF„ has a luteolytic effect la 
in human CL of the mid-luteal phase. 
3) Ovarian stroma: Specimens from the cortical stroma of postmenopausal 
ovaries were examined histologically and signs of stromal hyperplasia were 
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found in 47% of the ovaries, while in the remaining ovaries".the stroma 
appeared atrophic. Atrophic stroma produced measureable amounts of P, A and 
^2 in vitro, with A being the predominant steroid formed. Hyperplastic stroma 
produced 2-fold higher amounts of A and when compared to atrophic stroma. 
Human CG elicited a marked stimulation of cAMP formation in hyperplastic 
stroma but had no effect in atrophic stroma. The results clearly demonstrate 
that the endocrine function of the postmenopausal ovarian stroma varies with 
its histological appearance. Hyperplastic stroma exhibits a responsiveness 
to gonadotropin, has a clear-cut aromatizing capacity, and is steroidogeni-
cally more active than atrophic stroma. 
4) Hilus cells: Strips from the hilus tissue of postmenopausal ovaries were 
examined histologically and were found to contain clusters of typical hilus 
cells. When these specimens were incubated, measureable amounts of P, A and 
E2 were produced. A was the major steroid formed, but the formation of 
was unexpectedly high. The hilus cells responded to hCG with increased cAMP 
formation and markedly increased formation of E , while P formation was 
stimulated only slightly. The results demonstrate that the hilus cells of 
the postmenopausal ovary have a similar, although qualitatively stronger, 
steroidogenic capacity to the stromal cells and, further, that the hilus 
cells are capable of responding to gonadotropic stimulation. 
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